Cargando…
Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113938/ https://www.ncbi.nlm.nih.gov/pubmed/36786279 http://dx.doi.org/10.17305/bb.2022.8874 |
_version_ | 1785027925012119552 |
---|---|
author | Vranic, Semir |
author_facet | Vranic, Semir |
author_sort | Vranic, Semir |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10113938 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina |
record_format | MEDLINE/PubMed |
spelling | pubmed-101139382023-04-20 Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes Vranic, Semir Biomol Biomed Editorial Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2023-04-01 2023-03-16 /pmc/articles/PMC10113938/ /pubmed/36786279 http://dx.doi.org/10.17305/bb.2022.8874 Text en © 2023 Vranic. https://creativecommons.org/licenses/by/4.0/This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Editorial Vranic, Semir Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes |
title | Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes |
title_full | Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes |
title_fullStr | Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes |
title_full_unstemmed | Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes |
title_short | Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes |
title_sort | sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113938/ https://www.ncbi.nlm.nih.gov/pubmed/36786279 http://dx.doi.org/10.17305/bb.2022.8874 |
work_keys_str_mv | AT vranicsemir sacituzumabgovitecanexpandsitstherapeuticspectrumamongbreastcancersubtypes |